ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 6,260.00
+80.00 (1.29%)
At close: Sep 3, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 134.89 billion as of September 4, 2026. Its market cap has increased by 73.81% in one year.
Market Cap
134.89B
Enterprise Value
97.59B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
6,260.00
ChartMarket Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 134.89B, a decrease of -75.97%. That is a compound annual growth rate of -24.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 134.89B | -32.51% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 179.65B |
| NIBEC | 172.34B |
| Bio Solution | 156.89B |
| Ensol Biosciences | 146.21B |
| ISU Abxis | 138.43B |
| Prestige Biologics | 133.81B |
| Y-Biologics | 133.38B |
| TiumBio | 131.27B |